Amoroso, Jennifer I.
HRN: 18-44-05 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/22/2022
CEFUROXIME 500MG (TAB)
09/22/2022
09/29/2022
ORAL
500mg
BID
Post CS
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes